MyFinsight
Home
About
Contact
Back
Income Statement
Salarius Pharmaceuticals, Inc. (SLRX)
source: myfinsight.com
Download
Download image
Net loss
-$957,825
Loss from continuing
operations
-$957,825
Interest income, net
$7,740
Loss before other
income (expense)
-$965,565
Total operating
expenses
$965,565
General and
administrative
$849,182
Research and development
$116,383
Back